| Literature DB >> 27711237 |
Yu Wang1, Hua Guan1, Da-Fei Xie1, Yi Xie2, Xiao-Dan Liu1, Qi Wang1, Li Sui3, Man Song1,4, Hong Zhang2, Jianhua Zhou5,6, Ping-Kun Zhou1,4.
Abstract
Radiotherapy with heavy ions is considered advantageous compared to irradiation with photons due to the characteristics of the Braggs peak and the high linear energy transfer (LET) value. To understand the mechanisms of cellular responses to different LET values and dosages of heavy ion radiation, we analyzed the proteomic profiles of mouse embryo fibroblast MEF cells exposed to two doses from different LET values of heavy ion 12C. Total proteins were extracted from these cells and examined by Q Exactive with Liquid Chromatography (LC)-Electrospray Ionization (ESI) Tandem MS (MS/MS). Using bioinformatics approaches, differentially expressed proteins with 1.5 or 2.0-fold changes between different dosages of exposure were compared. With the higher the dosage and/or LET of ion irradiation, the worse response the cells were in terms of protein expression. For instance, compared to the control (0 Gy), 771 (20.2%) proteins in cells irradiated at 0.2 Gy of carbon-ion radiation with 12.6 keV/μm, 313 proteins (8.2%) in cells irradiated at 2 Gy of carbon-ion radiation with 12.6 keV/μm, and 243 proteins (6.4%) in cells irradiated at 2 Gy of carbon-ion radiation with 31.5 keV/μm exhibited changes of 1.5-fold or greater. Gene ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, Munich Information Center for Protein Sequences (MIPS) analysis, and BioCarta analysis all indicated that RNA metabolic processes (RNA splicing, destabilization and deadenylation) and proteasome pathways may play key roles in the cellular response to heavy-ion irradiation. Proteasome pathways ranked highest among all biological processes associated with heavy carbon-ion irradiation. In addition, network analysis revealed that cellular pathways involving proteins such as Col1a1 and Fn1 continued to respond to high dosages of heavy-ion irradiation, suggesting that these pathways still protect cells against damage. However, pathways such as those involving Ikbkg1 responded better at lower dosages than at higher dosages, implying that cell damage would occur when the networks involving these proteins stop responding. Our investigation provides valuable proteomic information for elucidating the mechanism of biological effects induced by carbon ions in general.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27711237 PMCID: PMC5053480 DOI: 10.1371/journal.pone.0163896
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Proteins differentially expressed in cells exposed to 0.2 Gy low and 2 Gy high doses of carbon ions with different LET values.
(A) Venn diagram showing distinct and overlapping proteins differentially regulated among these three groups of carbon ion-irradiated cells. (B) Correlation analysis of protein expression changes among the three groups. The corresponding correlation coefficients are shown in the top right corner.
Fig 2Analyses of proteins expression changes by immunoblotting hybridization.
The altered expression levels of H2A1, SOX14, RanGAP1, γH2AX, and PI3K-III were verified in the cells after irradiation with carbon ions at an LET value of 12.6 keV/μm or 31.5 keV/μm. The cell extracts for immunoblotting were prepared at 4 h after irradiation. β-actin expression was used as a sample loading control.
Top-ranked pathways by GO analysis.
| Rank | Pathway | Pathway size | Observed | Ratio | |
|---|---|---|---|---|---|
| 1 | CYTOPLASM | 2130 | 165 | 0.077 | 4.6E-64 |
| 2 | RNA_BINDING | 259 | 43 | 0.166 | 5.5E-30 |
| 3 | RNA_SPLICING | 91 | 22 | 0.242 | 1.1E-19 |
| 4 | RNA_PROCESSING | 173 | 30 | 0.173 | 7.0 E-22 |
| 5 | RIBONUCLEOPROTEIN_COMPLEX | 143 | 26 | 0.182 | 1.1E-19 |
| 6 | MRNA_PROCESSING_GO_0006397 | 73 | 16 | 0.219 | 5.4E-14 |
| 7 | RNA_SPLICING_FACTOR_ACTIVITYTRANSESTERIFICATION_MECHANISM | 19 | 7 | 0.368 | 1.4E-08 |
| 8 | MRNA_METABOLIC_PROCESS | 84 | 17 | 0.202 | 3.6E-14 |
| 9 | NUCLEUS | 1428 | 104 | 0.073 | 2.6E-37 |
| 10 | DRUG_BINDING | 16 | 6 | 0.375 | 1.4E-07 |
| 11 | CYTOPLASMIC_PART | 1383 | 100 | 0.072 | 1.3E-35 |
| 12 | PROTEIN_FOLDING | 58 | 13 | 0.224 | 9.3E-12 |
Top-ranked pathways by REACTOME analysis.
| Rank | Pathway | Pathway size | Observed | Ratio | |
|---|---|---|---|---|---|
| 1 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | 82 | 29 | 0.353 | 2.1E-11 |
| 2 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | 51 | 19 | 0.372 | 2.3E-08 |
| 3 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | 48 | 18 | 0.375 | 4.8E-08 |
| 4 | REACTOME_MRNA_SPLICING | 109 | 29 | 0.266 | 1.1E-07 |
| 5 | REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G | 51 | 18 | 0.352 | 2.0E-07 |
| 6 | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | 47 | 17 | 0.361 | 2.7E-07 |
| 7 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | 47 | 17 | 0.361 | 2.7E-07 |
| 8 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | 63 | 20 | 0.317 | 4.7E-07 |
| 9 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | 49 | 17 | 0.346 | 6.7E-07 |
| 10 | REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT | 49 | 17 | 0.346 | 6.7E-07 |
| 11 | REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21 | 54 | 18 | 0.333 | 7.1E-07 |
| 12 | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | 50 | 17 | 0.34 | 1.0E-06 |
Top-ranked pathways by BioCarta analysis.
| Rank | Pathway | Pathway size | Observed | Ratio | |
|---|---|---|---|---|---|
| 1 | BIOCARTA_PROTEASOME_PATHWAY | 28 | 16 | 0.571 | 1.7E-20 |
| 2 | BIOCARTA_GLYCOLYSIS_PATHWAY | 10 | 5 | 0.5 | 7.7E-07 |
| 3 | BIOCARTA_P53HYPOXIA_PATHWAY | 23 | 7 | 0.304 | 2.4E-07 |
| 4 | BIOCARTA_PTDINS_PATHWAY | 23 | 7 | 0.304 | 2.4E-07 |
| 5 | BIOCARTA_NDKDYNAMIN_PATHWAY | 19 | 5 | 0.263 | 2.9E-05 |
| 6 | BIOCARTA_INTEGRIN_PATHWAY | 38 | 7 | 0.184 | 9.0E-06 |
| 7 | BIOCARTA_FREE_PATHWAY | 10 | 3 | 0.3 | 0.0008 |
| 8 | BIOCARTA_GABA_PATHWAY | 10 | 3 | 0.3 | 0.0008 |
| 9 | BIOCARTA_GLEEVEC_PATHWAY | 23 | 5 | 0.217 | 7.7E-05 |
| 10 | BIOCARTA_CK1_PATHWAY | 17 | 4 | 0.235 | 0.0003 |
| 11 | BIOCARTA_P35ALZHEIMERS_PATHWAY | 11 | 3 | 0.272 | 0.0011 |
| 12 | BIOCARTA_SET_PATHWAY | 11 | 3 | 0.272 | 0.0011 |
Top-ranked pathways by KEGG analysis.
| Rank | Pathway | Pathway size | Observed | Ratio | |
|---|---|---|---|---|---|
| 1 | KEGG_SPLICEOSOME | 127 | 38 | 0.299 | 1.4E-10 |
| 2 | KEGG_PROTEASOME | 47 | 16 | 0.340 | 6.4E-06 |
| 3 | KEGG_RNA_DEGRADATION | 59 | 18 | 0.305 | 1.2E-05 |
| 4 | KEGG_GLUTATHIONE_METABOLISM | 50 | 13 | 0.26 | 0.0015 |
| 5 | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 34 | 9 | 0.264 | 0.0088 |
| 6 | KEGG_FOCAL_ADHESION | 200 | 27 | 0.135 | 0.012 |
| 7 | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 62 | 11 | 0.177 | 0.048 |
| 8 | KEGG_PROTEIN_EXPORT | 24 | 6 | 0.25 | 0.050 |
| 9 | KEGG_PENTOSE_PHOSPHATE_PATHWAY | 27 | 6 | 0.222 | 0.082 |
| 10 | KEGG_PYRUVATE_METABOLISM | 40 | 7 | 0.175 | 0.14 |
| 11 | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 51 | 8 | 0.157 | 0.16 |
| 12 | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 25 | 5 | 0.2 | 0.16 |
Fig 3Network analysis of differentially expressed proteins with 1.5-fold changes.
(A) The network of differentially expressed proteins from the cells irradiated by 0.2 Gy of carbon-ion radiation with an LET of 12.6 keV/μm. (B) The network of differentially expressed proteins from the cells irradiated by 2 Gy of carbon-ion radiation with an LET of 12.6 keV/μm. (C) The network of differentially expressed proteins from the cells irradiated by 2 Gy of carbon-ion radiation with an LET of 31.5 keV/μm.
Fig 4Network analysis of differentially expressed proteins with changes of 2.0-fold or greater in irradiated by 0.2 Gy of carbon-ion radiation with an LET of 12.6 keV/μm.
Fig 5Network analysis of differentially expressed proteins with changes of 2.0-fold or greater in the cells irradiated by 2 Gy of carbon-ion radiation, with an LET of 12.6 keV/μm.
Top-ranked pathways by MIPS analysis.
| Rank | Pathway | Pathway size | Observed | Ratio | |
|---|---|---|---|---|---|
| 1 | MIPS_PA28_20S_PROTEASOME | 16 | 13 | 0.812 | 2.3E-17 |
| 2 | MIPS_26S_PROTEASOME | 22 | 15 | 0.681 | 1.8E-15 |
| 3 | MIPS_PA700_20S_PA28_COMPLEX | 36 | 16 | 0.444 | 4.1E-09 |
| 4 | MIPS_SPLICEOSOME | 142 | 35 | 0.246 | 3.7E-08 |
| 5 | MIPS_ESCRT_III_COMPLEX | 10 | 6 | 0.6 | 9.0E-06 |
| 6 | MIPS_TNF_ALPHA_NF_KAPPA_B_SIGNALING_COMPLEX_10 | 10 | 6 | 0.6 | 9.0E-06 |
| 7 | MIPS_C_COMPLEX_SPLICEOSOME | 80 | 20 | 0.25 | 3.9E-05 |
| 8 | MIPS_EXOSOME | 11 | 5 | 0.454 | 0.0013 |
| 9 | MIPS_CDC5L_COMPLEX | 30 | 8 | 0.266 | 0.0090 |
| 10 | MIPS_HCF_1_COMPLEX | 19 | 4 | 0.315 | 0.0098 |
| 11 | MIPS_LARGE_DROSHA_COMPLEX | 20 | 3 | 0.3 | 0.0011 |
| 12 | MIPS_12S_U11_SNRNP | 15 | 3 | 0.333 | 0.0011 |
Top-ranked pathways by PID analysis.
| Rank | Pathway | Pathway size | Observed | Ratio | |
|---|---|---|---|---|---|
| 1 | PID_ILK_PATHWAY | 45 | 9 | 0.2 | 0.0335 |
| 2 | PID_IGF1_PATHWAY | 30 | 6 | 0.2 | 0.0955 |
| 3 | PID_IL1PATHWAY | 34 | 6 | 0.176 | 0.1437 |
| 4 | PID_PI3KPLCTRKPATHWAY | 36 | 6 | 0.166 | 0.1694 |
| 5 | PID_LIS1PATHWAY | 28 | 5 | 0.178 | 0.1861 |
| 6 | PID_AVB3_INTEGRIN_PATHWAY | 75 | 9 | 0.12 | 0.2229 |
| 7 | PID_UPA_UPAR_PATHWAY | 42 | 6 | 0.142 | 0.2479 |
| 8 | PID_NFAT_3PATHWAY | 54 | 7 | 0.129 | 0.2552 |
| 9 | PID_RHOA_PATHWAY | 45 | 6 | 0.133 | 0.2866 |
| 10 | PID_SYNDECAN_1_PATHWAY | 46 | 6 | 0.130 | 0.2993 |
| 11 | PID_LYMPHANGIOGENESIS_PATHWAY | 25 | 4 | 0.16 | 0.3098 |
| 12 | PID_FOXOPATHWAY | 49 | 6 | 0.122 | 0.3364 |